StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.64−0.00 (-0.28%)

Close on Nov 17, 2026Market cap $1.96MP/E –Yield –

DataMeds AI ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

DataMeds AI's ebitda for the twelve months ending Sep 30, 2026 was -$40.21M. For fiscal 2025 it was -$90.54M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$90.54M–
FY2024Dec 31, 2024-$5.03M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.02M–
Q2 FY2026Jun 30, 2026-$6.99M–
Q1 FY2026Mar 31, 2026-$5.66M–
Q4 FY2025Dec 31, 2025-$24.55M–
Q3 FY2025Sep 30, 2025-$30.75M–
Q2 FY2025Jun 30, 2025-$4.70M–
Q1 FY2025Mar 31, 2025-$30.55M–
Q4 FY2024Dec 31, 2024-$3.10M–
Q3 FY2024Sep 30, 2024-$1.28M–

More DataMeds AI figures

See a number that looks wrong?